Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
Travere Therapeutics, Inc.
Hiddo J L Heerspink; Jai Radhakrishnan; Charles E Alpers; Jonathan Barratt; Stewart Bieler; Ulysses Diva; Jula Inrig; Radko Komers; Alex Mercer; Irene L Noronha; Michelle N Rheault; William Rote; Brad Rovin; Howard Trachtman; Hernán Trimarchi; Muh Geot Wong; Vlado Perkovic; PROTECT Investigators